Filing Details
- Accession Number:
- 0000899243-19-010036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-04 20:00:38
- Reporting Period:
- 2019-04-02
- Accepted Time:
- 2019-04-04 20:00:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1399529 | Dicerna Pharmaceuticals Inc | DRNA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598480 | B James Weissman | C/O Dicerna Pharmaceuticals, Inc. 87 Cambridgepark Drive Cambridge MA 02140 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-02 | 15,000 | $3.42 | 39,480 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-02 | 15,000 | $15.00 | 24,480 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-02 | 15,000 | $0.00 | 15,000 | $3.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,699 | 2023-09-24 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2018.
- The vesting of this option was subject to achievement of pre-established performance goals. As of the transaction date, 100% of the option (representing 60,000 shares) was vested.
Billionaire Hedge Funds
